Discover more about POLIVY for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).
Learn more about the key data highlights presented at congresses and how they could impact UK clinical practice.
For full details, please refer to the Gazyvaro® or Polivy® Summary of Product Characteristics.
1L, first-line; FL, follicular lymphoma; R/R, relapsed/refractory; CLL, chronic lymphocytic leukaemia; DLBCL, diffuse large B-cell lymphoma.
Date of preparation: September 2020